Crispr Therapeutics Stock Been: A Roller-Coaster Year Unpacked
CRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
Explore the value of credit card rewards points. Learn how to maximize your rewards for travel and other savings opportunities.
23,575 articlesCRISPR Therapeutics stock has zigzagged all year, driven by pipeline milestones, regulatory updates, and funding need...
STRC slid to a deep intraday low near $82.61 on June 18 before rebounding, signaling distress in the Bitcoin-linked d...
OpenAI's ongoing losses highlight the high-cost path of AI leadership. This article explains why two blue-chip AI sto...
When Alphabet stock just crashed, investors hunted for real reasons beyond headlines. This guide breaks down the core...
Grayscale argues that saylor’s strategy $1.5bb cashflow is being squeezed by a growing load of preferred-stock obliga...
Alpha Omega Semiconductor stock has doubled this year, but is the rally justified? This guide breaks down the busines...
San Francisco-based Framework Ventures closes its fourth fund at $400 million, expanding beyond crypto into frontier ...
What happens when AI breakthroughs and high-flying tech bets collide with political markets? This article explains th...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
Nuvation Bio has surged, even as an insider sold a meaningful stake. This piece breaks down what the move means, how ...
A major shakeup in AI deals spotlights coding as a premier use case for generative AI. Google hires Windsurf talent a...
Meta’s foray into cloud services, dubbed Meta Compute, sparks a selloff in AI infrastructure peers Nebius, CoreWeave,...